Targeting vascular redox biology through antioxidant gene delivery: a historical view and current perspectives

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Cardiovascular Research

Background:

• Oxidative stress, an imbalance in superoxide and nitric oxide (NO) production, drives vascular diseases including atherosclerosis and hypertension.
• Previous oral antioxidant trials yielded disappointing results, prompting exploration of novel therapeutic strategies.
• Gene therapy offers a promising avenue to modulate NO bioavailability and mitigate oxidative stress in vascular disease models.

Purpose of the Study:

• To review the potential of gene delivery strategies for treating vascular diseases by targeting oxidative stress and NO pathways.
• To discuss the application of gene therapy for enhancing NO production and antioxidant enzyme expression in the vascular wall.
• To explore novel gene delivery methods and their relevance to treating vascular conditions.

Main Methods:

• Review of preclinical studies on gene delivery of NO-producing enzymes (e.g., endothelial NO synthase) and antioxidant enzymes (e.g., heme oxygenase-1, superoxide dismutase).
• Investigation of strategies involving transfection with secreted antioxidants like high-density lipoprotein-associated enzymes or soluble scavenger receptors.
• Discussion of the challenges and advancements in achieving specific gene delivery to the vascular wall.

Main Results:

• Gene delivery of endothelial NO synthase can increase NO production, while antioxidative enzymes can attenuate oxidative stress and inhibit atherosclerosis in preclinical models.
• Secreted antioxidants offer an alternative approach, potentially bypassing the need for endothelium-specific gene delivery.
• Ongoing development of targeted gene delivery techniques to the vascular wall shows future therapeutic potential.

Conclusions:

• Gene therapy, particularly the delivery of antioxidant and NO-modulating enzymes, presents a promising strategy for managing vascular diseases.
• While challenges in targeted delivery remain, advancements suggest a hopeful future for gene-based treatments.
• Further research into vascular-specific gene delivery holds significant potential for treating atherosclerosis, hypertension, and related conditions.